Forte Biosciences Inc (FBRX)
4.48
+0.11
(+2.52%)
USD |
NASDAQ |
Nov 05, 11:29
Forte Biosciences Price to Book Value: 0.3857 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 0.3762 |
| November 01, 2024 | 0.3599 |
| October 31, 2024 | 0.3831 |
| October 30, 2024 | 0.3995 |
| October 29, 2024 | 0.3943 |
| October 28, 2024 | 0.3977 |
| October 25, 2024 | 0.4028 |
| October 24, 2024 | 0.3986 |
| October 23, 2024 | 0.4158 |
| October 22, 2024 | 0.4089 |
| October 21, 2024 | 0.3995 |
| October 18, 2024 | 0.4072 |
| October 17, 2024 | 0.3874 |
| October 16, 2024 | 0.402 |
| October 15, 2024 | 0.3973 |
| October 14, 2024 | 0.4089 |
| October 11, 2024 | 0.3917 |
| October 10, 2024 | 0.4141 |
| October 09, 2024 | 0.4305 |
| October 08, 2024 | 0.4305 |
| October 07, 2024 | 0.4313 |
| October 04, 2024 | 0.4322 |
| October 03, 2024 | 0.4305 |
| October 02, 2024 | 0.4395 |
| October 01, 2024 | 0.4442 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.4813 |
| September 27, 2024 | 0.4942 |
| September 26, 2024 | 0.5011 |
| September 25, 2024 | 0.5682 |
| September 24, 2024 | 0.6026 |
| September 23, 2024 | 0.6057 |
| September 20, 2024 | 0.6095 |
| September 19, 2024 | 0.6031 |
| September 18, 2024 | 0.5794 |
| September 17, 2024 | 0.6104 |
| September 16, 2024 | 0.625 |
| September 13, 2024 | 0.6267 |
| September 12, 2024 | 0.6035 |
| September 11, 2024 | 0.6113 |
| September 10, 2024 | 0.6113 |
| September 09, 2024 | 0.6526 |
| September 06, 2024 | 0.6552 |
| September 05, 2024 | 0.656 |
| September 04, 2024 | 0.6285 |
| September 03, 2024 | 0.6543 |
| August 30, 2024 | 0.6801 |
| August 29, 2024 | 0.6715 |
| August 28, 2024 | 0.6655 |
| August 27, 2024 | 0.7425 |
| August 26, 2024 | 0.7253 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3418
Minimum
Nov 15 2023
26.78
Maximum
Sep 30 2020
3.784
Average
0.7253
Median
Price to Book Value Benchmarks
| Theriva Biologics Inc | 0.0780 |
| CEL-SCI Corp | 5.867 |
| AIM ImmunoTech Inc | 2.605 |
| IGC Pharma Inc | 3.715 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 4.48 |
| Earnings Yield | -407.4% |
| Market Cap | 6.542M |